Genmin Stock Quote GEN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.035

Bid

0.035

Ask

0.036

Volume

424,216

0.035 Day's Range 0.035

0.034 52 Week Range 0.1725

Market Cap

23.983M

Previous Close

0.036

Open

0.035

Last Trade

50000

0.035

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

906,156

Shares Outstanding

685,229,436

Dividend Yield

PE Ratio

-1.56

Earnings Per Share (EPS)

-0.02

Revenue

32k

Net Profit

-13.18M

Sector

Metal Mining Services

Industry

Metal Mining Services

Website

genmingroup.com

Headquarters

Perth, Western Australia, Aus

Founded

Genmin Limited is listed in the Metal Mining Services sector of the Australian Stock Exchange with ticker GEN. The last closing price for Genmin was AUD0.04. Over the last year, Genmin shares have traded in a share price range of AUD 0.034 to AUD 0.1725.

Genmin currently has 685,229,436 shares outstanding. The market capitalization of Genmin is AUD24.67 million. Genmin has a price to earnings ratio (PE ratio) of -1.56.

Genmab Files IND for HuMax-TF-ADC

Company Announcement IND for HuMax(R)-TF-ADC submitted to FDA Genmab's first IND submission for antibody-drug conjugate (ADC) product Patient enrolment in clinical trial expected...

Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec refused re-hearing in Arzerra patent infringement case COPENHAGEN, Denmark, July 15, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN...

Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder

Company Announcement First Phase III study with subcutaneous formulation of ofatumumab Ofatumumab to be investigated in new autoimmune area - pemphigus vulgaris Patient...

Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhe

Media Release Antibody-drug conjugate (ADC) to be developed for cancer Combines strength of HuMax(R)-TAC with next generation PBD-based warhead technology 50:50 partnership ...

Teprotumumab Restarts Clinical Development in New Indication

Company Announcement Teprotumumab (RG1507) to be investigated for new indication River Vision Development Corporation to conduct clinical development under a license from Roche...

Genmab Launches Sponsored Level 1 American Depositary Receipt (ADR) Program

Company Announcement Genmab establishes Sponsored Level 1 ADR program Genmab ADRs can be traded on US over-the-counter (OTC) market effective today ADR ticker symbol GMXAY...

GSK and Genmab Announce Positive Top-Line Results From Pivotal Study of ARZERRA(R) (ofatumumab) Combined With Chlorambucil in P

Company Announcement Median 22.4 month progression free survival in patients treated with ofatumumab plus chlorambucil, an improvement of 9.3 months compared to chlorambucil alone No...

Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark, May 17, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced...

Genmab Announces Financial Results for the First Quarter of 2013

COPENHAGEN, Denmark, May 7, 2013 (GLOBE NEWSWIRE) -- Interim Report First Quarter 2013 Arzerra(r) received approval in Japan Arzerra net sales increased 65% over Q1...

Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocy

Company Announcement 95% overall response rate and 43% complete response rate in patients with previously untreated chronic lymphocytic leukemia 74% overall response rate and 11...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.004	-10.2564102564	0.039	0.039	0.034	1117257	0.03582745	DE
4	-0.015	-30	0.05	0.05	0.034	1125194	0.04207733	DE
12	-0.039	-52.7027027027	0.074	0.085	0.034	906156	0.04911592	DE
26	-0.085	-70.8333333333	0.12	0.15	0.034	562313	0.06696279	DE
52	-0.065	-65	0.1	0.1725	0.034	765803	0.086055	DE
156	-0.12	-77.4193548387	0.155	0.28	0.034	368085	0.1266216	DE
260	-0.285	-89.0625	0.32	0.34	0.034	387756	0.16431862	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EUROBEuropean Lithium Limited	AUD 0.004 (100.00%)	730k
TX3Trinex Minerals Ltd	AUD 0.002 (100.00%)	1.02M
EXTODExcite Technology Services Ltd	AUD 0.003 (50.00%)	24.77M
GGEGrand Gulf Energy Limited	AUD 0.003 (50.00%)	1M
M4MMacro Metals Ltd	AUD 0.0115 (43.75%)	19.2M
APCDBAustralian Potash Limited	AUD 0.002 (-50.00%)	2.99M
BDGBlack Dragon Gold Corp	AUD 0.019 (-40.63%)	10.59M
WC1OWest Cobar Metals Ltd	AUD 0.005 (-37.50%)	392.41k
TOEOToro Energy Limited	AUD 0.035 (-36.36%)	48.03k
CAECannindah Resources Ltd	AUD 0.042 (-33.33%)	3.9M
VMLVital Metals Limited	AUD 0.002 (0.00%)	66.93M
OVTOvanti Ltd	AUD 0.021 (-8.70%)	55.15M
GMNGold Mountain Limited	AUD 0.002 (0.00%)	48.42M
TMGTrigg Minerals Ltd	AUD 0.045 (0.00%)	41.52M
DEGDe Grey Mining Limited	AUD 1.955 (29.04%)	39.41M